Ruconest is a Intravenous Injection, Powder, For Solution in the Human Prescription Drug category. It is labeled and distributed by Santarus, Inc.. The primary component is Conestat Alfa.
| Product ID | 68012-350_1ee71ee6-7d7a-4543-bb0f-4b463801b5e1 |
| NDC | 68012-350 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Ruconest |
| Generic Name | C1 Esterase Inhibitor Recombinant |
| Dosage Form | Injection, Powder, For Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2014-09-22 |
| Marketing End Date | 2022-01-18 |
| Marketing Category | BLA / BLA |
| Application Number | BLA125495 |
| Labeler Name | Santarus, Inc. |
| Substance Name | CONESTAT ALFA |
| Active Ingredient Strength | 2100 U/1 |
| NDC Exclude Flag | N |
| Marketing Start Date | 2014-09-22 |
| Marketing End Date | 2022-01-18 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | BLA |
| Application Number | BLA125495 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2014-09-22 |
| Marketing End Date | 2022-01-18 |
| Marketing Category | BLA |
| Application Number | BLA125495 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2014-09-22 |
| Marketing End Date | 2022-01-18 |
| Ingredient | Strength |
|---|---|
| CONESTAT ALFA | 2100 U/1 |
| SPL SET ID: | 6f8b81df-48fe-4798-8d54-fc8f65888489 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 68012-350 | Ruconest | c1 esterase inhibitor recombinant |
| 69913-350 | Ruconest | c1 esterase inhibitor recombinant |
| 70383-350 | Ruconest | c1 esterase inhibitor recombinant |
| 71274-350 | Ruconest | c1 esterase inhibitor recombinant |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() RUCONEST 85134646 4095324 Live/Registered |
Pharming Intellectual Property B.V. 2010-09-21 |